Showing 1 - 5 results of 5 for search 'Charles S. Cleeland', query time: 0.03s
Refine Results
-
1
-
2
-
3
Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma by Charles S. Cleeland, Karen N. Keating, Brian Cuffel, Cem Elbi, Jonathan M. Siegel, Christoph Gerlinger, Tara Symonds, Jeff A. Sloan, Amylou C. Dueck, Andrew Bottomley, Xin Shelley Wang, Loretta A. Williams, Tito R. Mendoza
Published 2024-06-01
Article -
4
Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID) by Loretta A. Williams, Meagan S. Whisenant, Tito R. Mendoza, Angela E. Peek, Donna Malveaux, Donna K. Griffin, Darcy A. Ponce, Bruno Palma Granwehr, Ajay Sheshadri, Katherine A. Hutcheson, Sara M. Ali, Susan K. Peterson, John V. Heymach, Charles S. Cleeland, Ishwaria M. Subbiah
Published 2023-05-01
Article -
5
Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 ... by MD Anderson Head and Neck Cancer Symptom Working Group, Salman A. Eraj, Mona K. Jomaa, Crosby D. Rock, Abdallah S. R. Mohamed, Blaine D. Smith, Joshua B. Smith, Theodora Browne, Luke C. Cooksey, Bowman Williams, Brandi Temple, Kathryn E. Preston, Jeremy M. Aymard, Neil D. Gross, Randal S. Weber, Amy C. Hessel, Renata Ferrarotto, Jack Phan, Erich M. Sturgis, Ehab Y. Hanna, Steven J. Frank, William H. Morrison, Ryan P. Goepfert, Stephen Y. Lai, David I. Rosenthal, Tito R. Mendoza, Charles S. Cleeland, Kate A. Hutcheson, Clifton D. Fuller, Adam S. Garden, G. Brandon Gunn
Published 2017-11-01
Article